Fernando Vargas

[Fernando Vargas @fvarmad]

@RahulBanerjeeMD @mtmdphd @szusmani Good news for patients. What was the OS difference between groups?

[Fernando Vargas @fvarmad]

@LeukDocJZ @mtmdphd @beatalleukemia @bcutd_research Was OS data presented?

[Fernando Vargas @fvarmad]

@Charles_Herbaux No role for frontMIND outside of very specific situations. Pola-RCHP or RCHOP still the way to go in my book.

[Fernando Vargas @fvarmad]

@tobyeyre82 Practice changing for whom?

Will need to see the publication to get the details of the patient, response on TP53 WT, LoT, etc..

[Fernando Vargas @fvarmad]

@jamecancerdoc @ASCO @OncoAlert Lets take a step back before comparing it to imatinib… perhaps only ATRA deserves to share that podium.

But otherwise fantastic results and hope for mPDAC patients!

[Fernando Vargas @fvarmad]

@HemSandoval @GuiperiniMD Why give 7 drugs if you can give 5 (ie pola-rchp). Less is more until proven otherwise.

[Fernando Vargas @fvarmad]

@Arraya_Tennis Grande Nacho! Ese ultimo punto del segundo set.. una LOCURA 🤯

[Fernando Vargas @fvarmad]

@Papa_Heme Lets do Allo’s for high count MBL..

[Fernando Vargas @fvarmad]

@EdithaTogo @drjohnm I can’t speak for surgical specialties. For non-procedural its based on complexity or time spent.

[Fernando Vargas @fvarmad]

@DrNeilStone These ignorants think ivermectin is some sort of alien technology solving everything… 😂

[Fernando Vargas @fvarmad]

@RonDeSantis Glad some Republicans were responsible enough to stop such a non-sensical proposal.

[Fernando Vargas @fvarmad]

@EricTopol @JAMA_current As long as the evidence doesn’t support whole body MRI screening that consent sounds correct.

[Fernando Vargas @fvarmad]

@dgermain21 @Papa_Heme I agree that there are diffferent levels of review articles and learning has to be multifaceted.. but for example the last review article Eli Estey did in AML was excellent.

[Fernando Vargas @fvarmad]

@dgermain21 @Papa_Heme For fellows? Good review articles are highly valuable… as they can bring a great overview about a disease state. Its different for day to day practice.

[Fernando Vargas @fvarmad]

@HadidiSamer You are being kind… this is a borderline unethical study. The fact we can do something doesn’t mean we should.

[Fernando Vargas @fvarmad]

@Papa_Heme This is crazy… If any of these patient gets a t-MN will the investigators feel any guilt? I guess when you have enough funding you can just do any trial..

[Fernando Vargas @fvarmad]

@Papa_Heme Dara in MGUS… seems a bit unethical IMO. Wouldn’t enroll any family member into something like this.

[Fernando Vargas @fvarmad]

@AhmadRehanKhan Interestingly she doesn’t share that the only studies looking at outcomes of patients treated by IMGs vs US grads shows either equal outcomes or slightly better in the IMGs group. Realistically speaking outcomes are likely equal.

[Fernando Vargas @fvarmad]

@DrBruggeman This is were AI should be used to optimize the process. It could quickly review the evidence and quick turn around.